Zhang XY - Search Results

1

Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century.

Bei LY, Shang CY, Wu JZ, Shen HR, Yin H, Liang JH, Zhang XY, Wang L, Li JY, Li Y, Xu W. Bei LY, et al. Among authors: zhang xy. Ann Hematol. 2024 May;103(5):1675-1685. doi: 10.1007/s00277-024-05619-w. Epub 2024 Jan 16. Ann Hematol. 2024. PMID: 38228775

2

Negative prognostic impact of low absolute CD4⁺ T cell counts in peripheral blood in mantle cell lymphoma.

Zhang XY, Xu J, Zhu HY, Wang Y, Wang L, Fan L, Wu YJ, Li JY, Xu W. Zhang XY, et al. Cancer Sci. 2016 Oct;107(10):1471-1476. doi: 10.1111/cas.13020. Epub 2016 Sep 14. Cancer Sci. 2016. PMID: 27465799 Free PMC article.

3

DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.

Zhang XY, Liang JH, Wang L, Zhu HY, Wu W, Cao L, Fan L, Li JY, Xu W. Zhang XY, et al. J Cancer Res Clin Oncol. 2019 Jan;145(1):117-127. doi: 10.1007/s00432-018-2771-9. Epub 2018 Oct 16. J Cancer Res Clin Oncol. 2019. PMID: 30327941

4

Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma.

Zhou XH, Zhang XY, Liang JH, Zhu HY, Wang L, Xia Y, Cao L, Wu W, Fan L, Li JY, Xu W. Zhou XH, et al. Among authors: zhang xy. Cancer Biomark. 2019;24(4):439-447. doi: 10.3233/CBM-182193. Cancer Biomark. 2019. PMID: 30932881

5

Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia.

Pan B, Li Y, Xu Z, Miao Y, Yin H, Kong Y, Zhang X, Liang J, Xia Y, Wang L, Li J, Wu J, Xu W. Pan B, et al. Front Immunol. 2022 Oct 6;13:962000. doi: 10.3389/fimmu.2022.962000. eCollection 2022. Front Immunol. 2022. PMID: 36275721 Free PMC article.

6

Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia.

Xu Z, Pan B, Miao Y, Li Y, Qin S, Liang J, Kong Y, Zhang X, Tang J, Xia Y, Zhu H, Wang L, Li J, Wu J, Xu W. Xu Z, et al. Clin Exp Med. 2023 Oct;23(6):2651-2662. doi: 10.1007/s10238-023-01003-6. Epub 2023 Feb 4. Clin Exp Med. 2023. PMID: 36738306

7

Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia.

Xu Z, Pan B, Li Y, Xia Y, Liang J, Kong Y, Zhang X, Tang J, Wang L, Li J, Xu W, Wu J. Xu Z, et al. Int J Gen Med. 2023 Apr 26;16:1541-1553. doi: 10.2147/IJGM.S399629. eCollection 2023. Int J Gen Med. 2023. PMID: 37131869 Free PMC article.

8

Severe hemolytic exacerbations of Chinese PNH patients infected SARS-CoV-2 Omicron.

Yang H, Chai X, Gong Y, Zhang X, Wang L, Zhou X, Chen X, Xu J, Xu D, He G, Li J. Yang H, et al. Immun Inflamm Dis. 2023 Aug;11(8):e966. doi: 10.1002/iid3.966. Immun Inflamm Dis. 2023. PMID: 37647437 Free PMC article.

9

Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.

Gong Y, Zhang X, Chen X, Yang H, Zhang Y, He G, Li J. Gong Y, et al. Ann Hematol. 2024 Mar;103(3):1007-1009. doi: 10.1007/s00277-023-05549-z. Epub 2023 Nov 27. Ann Hematol. 2024. PMID: 38010407 No abstract available.

10

PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.

Liang JH, Wang WT, Wang R, Gao R, Du KX, Duan ZW, Zhang XY, Li Y, Wu JZ, Yin H, Shen HR, Wang L, Li JY, Guo JR, Xu W. Liang JH, et al. Among authors: zhang xy. Cancer Lett. 2024 Jun 1;591:216877. doi: 10.1016/j.canlet.2024.216877. Epub 2024 Apr 13. Cancer Lett. 2024. PMID: 38615930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,873 results

Search Page

Filters